Canadian Cyclist


March 26/18 14:30 pm - Drouin Receives Four Year Suspension

Posted by Editor on 03/26/18

The Canadian Centre for Ethics in Sport (CCES) announced today that David Drouin, a cycling athlete, received a four-year sanction for an anti-doping rule violation. The athlete's urine sample, collected during out-of-competition doping control on December 4, 2016, revealed the presence of SARM RAD-140, a prohibited anabolic agent.

In his original hearing, David Drouin argued that he drank from a tainted water bottle, which caused the positive. His brother, Jean-Philippe, admitted in the hearing to using the banned substance SARM RAD-140 for body building and that he had taken drinks from bottles in a shared refrigerator. Testimony from CCES doping expert Dr Christine Ayotte said it was very unlikely that David Drouin could have produced the concentrations in the test sample from a contaminated bottle.


2016 Tour de Beauce


In response to the CCES' notification of the adverse analytical finding, Mr. Drouin admitted the anti-doping rule violation and a hearing was held to determine the appropriate sanction length. Arbitrator Patrice Brunet imposed a sanction of four years ineligibility from sport, terminating January 25, 2021.

After receiving the arbitrator's decision, the athlete attempted to file an appeal [of the four year sanction, asking for two years] under Canadian Anti-Doping Program (CADP) Rule 13.2. On February 8, 2018 a second hearing was held regarding the athlete's attempted appeal. Following this second hearing, arbitrator Yves Fortier dismissed the athlete's appeal thereby confirming the four-year period of ineligibility.

The athlete, who resides in Saint-Prosper, Quebec, is ineligible to participate in any capacity with any sport signatory to the CADP, including training with teammates.

Original Sanction Decision

Appeal decision


Return to Canadian Cyclist homepage | Back to Top

 Privacy Policy | Contact | Subscribe to RSS Feed  | Logout
 © Copyright 1998-2021 Canadian Cyclist. All rights reserved.